Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) Invested Capital: 2021-2025

Historic Invested Capital for Molecular Partners Ag (MOLN) over the last 4 years, with Sep 2025 value amounting to $140,196.

  • Molecular Partners Ag's Invested Capital fell 21.23% to $140,196 in Q3 2025 from the same period last year, while for Sep 2025 it was $140,196, marking a year-over-year decrease of 21.23%. This contributed to the annual value of $180,199 for FY2024, which is 18.41% down from last year.
  • As of Q3 2025, Molecular Partners Ag's Invested Capital stood at $140,196, which was down 6.59% from $150,083 recorded in Q2 2025.
  • Over the past 5 years, Molecular Partners Ag's Invested Capital peaked at $29.2 million during Q3 2021, and registered a low of $140,196 during Q3 2025.
  • For the 3-year period, Molecular Partners Ag's Invested Capital averaged around $241,544, with its median value being $212,644 (2024).
  • Its Invested Capital has fluctuated over the past 5 years, first plummeted by 99.00% in 2022, then soared by 152.35% in 2024.
  • Molecular Partners Ag's Invested Capital (Quarterly) stood at $187,259 in 2021, then soared by 45.38% to $272,230 in 2022, then declined by 17.86% to $223,613 in 2023, then fell by 19.07% to $180,963 in 2024, then decreased by 21.23% to $140,196 in 2025.
  • Its Invested Capital stands at $140,196 for Q3 2025, versus $150,083 for Q2 2025 and $156,935 for Q1 2025.